A carregar...
Clinical and preclinical treatment of urologic diseases with phosphodiesterase isoenzymes 5 inhibitors: an update
Phosphodiesterase isoenzymes 5 inhibitors (PDE5-Is) are the first-line therapy for erectile dysfunction (ED). The constant discoveries of nitric oxide (NO)/cyclic guanosine monophosphate (cGMP) cell-signaling pathway for smooth muscle (SM) control in other urogenital tracts (UGTs) make PDE5-Is promi...
Na minha lista:
| Publicado no: | Asian J Androl |
|---|---|
| Main Authors: | , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Medknow Publications & Media Pvt Ltd
2016
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5000795/ https://ncbi.nlm.nih.gov/pubmed/26620458 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/1008-682X.167721 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|